BMY261218P00030000 Option on Bristol Myers Squibb

BMY Stock  USD 59.94  0.72  1.22%   

Bristol Myers Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Bristol Total Stockholder Equity

Total Stockholder Equity

15 Billion

At this time, Bristol Myers' Total Stockholder Equity is fairly stable compared to the past year.

Bristol Myers Corporate Directors

Karen VousdenIndependent DirectorProfile
Michael BonneyIndependent DirectorProfile
Robert BertoliniIndependent DirectorProfile
Gerald StorchIndependent DirectorProfile

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.